Huaren Pharmaceutical Co., Ltd. (300110.SZ)

CNY 3.77

(-0.53%)

Market Cap (In CNY)

4.45 Billion

Revenue (In CNY)

1.63 Billion

Net Income (In CNY)

188.06 Million

Avg. Volume

20.08 Million

Currency
CNY
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
2.77-4.35
PE
-
EPS
-
Beta Value
0.382
ISIN
CNE100000SW1
CUSIP
-
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Mr. Xiaodong Yang
Employee Count
-
Website
https://www.qdhuaren.com
Ipo Date
2010-08-25
Details
Huaren Pharmaceutical Co., Ltd. produces and sells non-PVC soft bag infusions in China. The company offers doxofylline, levofloxacin hydrochloride, compound potassium hydrogen phosphate, and caffeine citrate, sodium chloride, glucose, glucose sodium potassium chloride, compound sodium chloride, sodium lactate ringer, compound electrolyte, and sterilized water injections. It also provides therapeutic infusion products for blood volume expansion, hemostasis, nervous and circulatory systems, anti-infection, anti-hepatitis, hepatitis adjuvant, anti-tumor, and carbohydrate metabolism; and medical instruments, such as disposable incision retractors, disposable cannula puncture devices disposable specimen extractors, abdominal suction tubes, incision retractor protectors, iodine solution protective caps, slip pads, respiratory oscillation expectoration machines, protective mask cup types, protective and foldable disposable masks, and medical protective masks. In addition, the company offers pharmaceutical packaging materials, including rubber stopper, carton, and membrane; rinsing fluid and API series products; and food and beverage, and medical skin care products. Huaren Pharmaceutical Co., Ltd. was founded in 1998 and is based in Qingdao, China.